Roche's innovation center finishes search for site head and appoints internal candidate
Swiss drug group Roche has appointed the interim site head of Roche Innovation Center Copenhagen as permanent successor of Bo Rode Hansen, who left his position a year ago. The new manager will prioritize continued integration and culture preservation.
Roche Innovation Center Copenhagen (RICC), which works with RNA-targeted drugs, has appointed the final successor of former site head, Bo Rode Hansen, who left his position last year in favor of the US startup Genevant Sciences.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
